新日本製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 化学 | 4931/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2021/12/30 | 日証協 | 543,197株 | 0% | 144,163株 | 0% | 511,686株 | 0% | 57,802株 | 0% |
2021/12/24 | 日証協 | 543,197株 | -3.22% | 144,163株 | +62.43% | 511,686株 | -1.97% | 57,802株 | +83.85% |
2021/12/17 | 日証協 | 561,288株 | -7.14% | 88,752株 | -72.32% | 521,985株 | -7.91% | 31,440株 | -82.62% |
2021/12/10 | 日証協 | 604,473株 | +16.56% | 320,603株 | +60.62% | 566,835株 | +9.22% | 180,916株 | +72.92% |
2021/12/03 | 日証協 | 518,588株 | -24.32% | 199,609株 | +83.25% | 518,985株 | -23.28% | 104,627株 | +316.66% |
2021/11/26 | 日証協 | 685,200株 | -11.09% | 108,926株 | -85.77% | 676,480株 | -10.55% | 25,111株 | -89.48% |
2021/11/19 | 日証協 | 770,632株 | +38.5% | 765,464株 | +87.51% | 756,285株 | +16.76% | 238,664株 | +137.46% |
2021/11/05 | 日証協 | 481,067株 | -10.58% | 136,758株 | -46.98% | 580,429株 | -9.72% | 55,104株 | -57.29% |
2021/10/29 | 日証協 | 537,967株 | +8.63% | 257,959株 | -48.4% | 642,920株 | -7.24% | 129,009株 | +35.02% |
2021/10/22 | 日証協 | 495,234株 | +17.34% | 499,880株 | +33.97% | 693,091株 | +10.98% | 95,548株 | +234.62% |
2021/10/15 | 日証協 | 422,042株 | -8.44% | 373,138株 | -45.38% | 624,525株 | -6.27% | 28,554株 | -82.26% |
2021/10/08 | 日証協 | 460,964株 | +17.41% | 683,168株 | +340.02% | 666,303株 | -10.44% | 160,922株 | -28.34% |
2021/10/01 | 日証協 | 392,617株 | -14.48% | 155,260株 | +112.58% | 743,996株 | +5.57% | 224,567株 | +99.21% |
2021/09/24 | 日証協 | 459,108株 | -4.91% | 73,036株 | -75.45% | 704,721株 | -2.28% | 112,731株 | +142.43% |
2021/09/17 | 日証協 | 482,815株 | +13.63% | 297,478株 | -3% | 721,195株 | +2.7% | 46,500株 | -59.43% |
2021/09/10 | 日証協 | 424,915株 | -21.79% | 306,685株 | +10.09% | 702,247株 | -3.01% | 114,604株 | -20.15% |
2021/09/03 | 日証協 | 543,273株 | -0.91% | 278,584株 | +192.27% | 724,059株 | +10.79% | 143,526株 | +548.21% |
2021/08/27 | 日証協 | 548,252株 | -4.7% | 95,317株 | -63.99% | 653,553株 | +0.86% | 22,142株 | -62.91% |
2021/08/20 | 日証協 | 575,286株 | -9.7% | 264,668株 | -31.45% | 647,953株 | -2.04% | 59,702株 | -70.1% |
※株式分割は考慮していませんのでご注意ください。
Page Top